halothane has been researched along with Hypertrophy, Left Ventricular in 2 studies
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rithalia, A | 1 |
| Hopkins, PM | 1 |
| Harrison, SM | 1 |
| Barbry, T | 1 |
| Le Guen, M | 1 |
| De Castro, V | 1 |
| Coriat, P | 1 |
| Riou, B | 1 |
| Vivien, B | 1 |
2 other studies available for halothane and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Effects of halothane on action potential configuration in sub-endocardial and sub-epicardial myocytes from normotensive and hypertensive rat left ventricle.
Topics: Action Potentials; Anesthetics, Inhalation; Animals; Endocardium; Halothane; Hypertension; Hypertrop | 2003 |
Minimum alveolar concentration of halogenated volatile anaesthetics in left ventricular hypertrophy and congestive heart failure in rats.
Topics: Anesthetics, Inhalation; Animals; Disease Progression; Dose-Response Relationship, Drug; Halothane; | 2007 |